Article info
PDFEditors’ commentary
Highlights from this issue
Citation
Highlights from this issue
Publication history
- Accepted February 18, 2021
- First published March 16, 2021.
Online issue publication
March 16, 2021
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- New-onset refractory status epilepticus (NORSE) in paediatric patients: causes, characteristics and outcomes
- New onset refractory status epilepticus (NORSE) as the heralding manifestation of herpes simplex encephalitis
- New-onset refractory status epilepticus (NORSE)
- Refractory status epilepticus complicated by drug-induced involuntary movements
- Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management
- Unusual cause of fever, vision loss and super refractory status epilepticus in association with simian virus 40 (SV40)
- Transient bradycardia induced by thiopentone sodium: a unique challenge in the management of refractory status epilepticus
- Oligoclonal IgG bands in chronic inflammatory polyradiculoneuropathies
- Pragmatic guide to peripheral nerve disease and the role of clinical biomarkers
- Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature